- Home
- DMRA vs DCOM Comparison
DMRA vs DCOM Comparison
Compare DMRA & DCOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DMRA | DCOM |
|---|---|---|
| Founded | 2011 | 1864 |
| Country | United States | United States |
| Employees | 7 | 902 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.6B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | DMRA | DCOM |
|---|---|---|
| Price | $21.40 | $37.88 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $43.00 | $37.80 |
| AVG Volume (30 Days) | ★ 356.8K | 252.5K |
| Earning Date | 05-11-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 2.81% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $21.40 |
| Revenue Next Year | N/A | $12.65 |
| P/E Ratio | ★ N/A | $14.81 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $16.50 | $25.63 |
| 52 Week High | $28.76 | $38.00 |
Technical Indicators
Market Signals| Indicator | DMRA | DCOM |
|---|---|---|
| Relative Strength Index (RSI) | 31.88 | 59.38 |
| Support Level | $16.50 | $34.86 |
| Resistance Level | $26.66 | N/A |
| Average True Range (ATR) | 1.61 | 0.86 |
| MACD | -0.37 | 0.04 |
| Stochastic Oscillator | 13.54 | 93.04 |
Price Performance
Historical ComparisonAbout DMRA Damora Therapeutics Inc. Common Stock
Damora Therapeutics Inc is a biotechnology company that aims to fundamentally redefine care for people with hematologic disorders. The group is advancing a new generation of biologics to treat mutant calreticulin-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis, where there is cruicial medical need for disease-modifying treatments. Its goal is to rapidly bring forward optimized therapies with broad mutation coverage and exceptional convenience to dramatically improve patient outcomes. The group's pipeline products are DMR-001, DMR-002, DMR-003, and GB3226.
About DCOM Dime Community Bancshares Inc.
Dime Community Bancshares Inc operates as a holding company. The company gathers deposits from customers within its market area and via the internet and invests them in multifamily residential, commercial real estate, commercial and industrial (C&I) loans, and one-to-four family residential real estate loans, and mortgage-backed securities, obligations of the U.S. government and government- sponsored enterprises (GSEs), and corporate debt and equity securities. The company has one reportable segment which is Community Banking.